Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals
Clinical trial NCT02344303 · COMPLETED
Trial details
- NCT number
- NCT02344303
- Sponsor
- Trevena Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.